Use of evidence-based therapy and survival in heart failure with reduced ejection fraction 2002-2011

被引：0
|
作者：
Thorvaldsen, T. [1 ]
Benson, L. [1 ]
Dahlstrom, U. [2 ]
Edner, M. [1 ]
Lund, L. H. [1 ]
机构：
[1] Karolinska Inst, Stockholm, Sweden
[2] Linkoping Univ Hosp, S-58185 Linkoping, Sweden
来源：
EUROPEAN HEART JOURNAL | 2012年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：964 / 964
页数：1
相关论文
共 50 条
  • [1] Use of evidence-based therapy in heart failure with reduced ejection fraction across age strata
    Stolfo, Davide
    Lund, Lars H.
    Becher, Peter Moritz
    Orsini, Nicola
    Thorvaldsen, Tonje
    Benson, Lina
    Hage, Camilla
    Dahlstrom, Ulf
    Sinagra, Gianfranco
    Savarese, Gianluigi
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (06) : 1047 - 1062
  • [2] Evidence-based Therapy in Older Patients with Heart Failure with Reduced Ejection Fraction
    Stolfo, Davide
    Sinagra, Gianfranco
    Savarese, Gianluigi
    [J]. CARDIAC FAILURE REVIEW, 2022, 8
  • [3] An evidence-based review of recent advances in therapy for heart failure with reduced ejection fraction (HFrEF)
    Raj, Leah
    Adhyaru, Bhavin
    [J]. POSTGRADUATE MEDICAL JOURNAL, 2016, 92 (1094) : 726 - 734
  • [4] Medication Management for heart failure with reduced ejection Fraction clinical Pearls for optimizing evidence-based therapy
    Barry, Arden R.
    Kosar, Lynette
    Koshman, Sheri L.
    Turgeon, Ricky D.
    [J]. CANADIAN FAMILY PHYSICIAN, 2021, 67 (12) : E329 - E336
  • [5] Evidence-Based Medical Therapy in Patients With Heart Failure With Reduced Ejection Fraction and Chronic Kidney Disease
    Beldhuis, Iris E.
    Lam, Carolyn S. P.
    Testani, Jeffrey M.
    Voors, Adriaan A.
    Van Spall, Harriette G. C.
    ter Maaten, Jozine M.
    Damman, Kevin
    [J]. CIRCULATION, 2022, 145 (09) : 693 - 712
  • [6] Rapid evidence-based sequencing of foundational drugs for heart failure and a reduced ejection fraction
    Packer, Milton
    McMurray, John J. V.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 (06) : 882 - 894
  • [7] Use of evidence-based therapy in heart failure with reduced ejection fraction across age strata (vol 24, pg 1047, 2022)
    不详
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (10) : 1995 - 1995
  • [8] Clinician challenges to evidence-based prescribing for heart failure and reduced ejection fraction: A qualitative evaluation
    Trinkley, Katy E.
    Dafoe, Ashley
    Malone, Daniel C.
    Allen, Larry A.
    Huebschmann, Amy
    Khazanie, Prateeti
    Lunowa, Cali
    Matlock, Daniel C.
    Suresh, Krithika
    Rosenberg, Michael A.
    Swat, Stanley A.
    Sosa, Aracely
    Morris, Megan A.
    [J]. JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2023, 29 (08) : 1363 - 1371
  • [9] The safety and tolerability of beta blockers in heart failure with reduced ejection fraction: is the current underutilization of this evidence-based therapy justified?
    Kiel, Richard. G.
    Deedwania, Prakash
    [J]. EXPERT OPINION ON DRUG SAFETY, 2015, 14 (12) : 1855 - 1863
  • [10] How much can ejection fraction be improved in patients with heart failure with reduced ejection fraction (HFrEF) by the early introduction of evidence-based heart failure medication?
    White, J. Joseph
    Caspi, T.
    Arabi, P.
    Mcgrath, S.
    Arshad, A.
    Small, J.
    Wilkins, S.
    Ferreira, B.
    Bowker, T. J.
    Roy, S. Dutta
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 196 - 196
12345